CytomX Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover CytomX Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $6.50, which forecasts a 52.94% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $10.

Price Target: $6.50 (+52.94%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$6.50	$6.00	$10
Change	+17.65%	+52.94%	+41.18%	+135.29%

* Price targets were last updated on Nov 11, 2025.

Analyst Ratings

The average analyst rating for CytomX Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	1	1	1	2	2
Buy	2	2	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	5	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $10	Strong Buy	Maintains	$5 → $10	+135.29%	Nov 11, 2025
Etzer Darout Barclays	Barclays	Buy Maintains $3.5 → $6	Buy	Maintains	$3.5 → $6	+41.18%	Oct 21, 2025
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $6	Buy	Initiates	$6	+41.18%	Sep 22, 2025
Etzer Darout Barclays	Barclays	Buy Initiates $3.5	Buy	Initiates	$3.5	-17.65%	Sep 17, 2025
Matthew Biegler Oppenheimer	Oppenheimer	Buy Initiates $7	Buy	Initiates	$7	+64.71%	Jul 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

85.41M

from 138.10M

-38.16%

from 138.10M

Revenue Next Year

42.09M

from 85.41M

-50.71%

from 85.41M

EPS This Year

-0.01

from 0.38

EPS Next Year

-0.39

from -0.01

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	68.43M	37.31M	53.16M	101.21M	138.10M	85.41M	42.09M
Revenue Growth	154.36%	-45.47%	42.48%	90.38%	36.45%	-38.16%	-50.71%
EPS	-1.40	-1.81	-1.51	-0.01	0.38	-0.01	-0.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	95.1M	107.1M
Avg	85.4M	42.1M
Low	77.9M	3.9M

Revenue Growth

Revenue Growth	2025	2026
High	-31.2%	25.4%
Avg	-38.2%	-50.7%
Low	-43.6%	-95.4%

EPS Forecast

EPS	2025	2026
High	0.06	-0.22
Avg	-0.01	-0.39
Low	-0.06	-0.53

EPS Growth

EPS Growth	2025	2026
High	-83.3%	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.